Seite - 27 - in Advances in Neuroimmunology

BrainSci. 2016,6, 15 4. VanWagoner,N.J.;Benveniste,E.N. Interleukin-6expressionandregulation inastrocytes. J.Neuroimmunol. 1999,100, 124–139. [CrossRef] 5. Milo,R.;Kahana,E.Multiplesclerosis:Geoepidemiology,geneticsandtheenvironment.Autoimmun.Rev. 2010,9,A387–A394. [CrossRef] [PubMed] 6. Baxter,A.G.Theoriginandapplicationofexperimentalautoimmuneencephalomyelitis.Nat. Rev. Immunol. 2007,7, 904–912. [CrossRef] [PubMed] 7. Merrill, J.E.;Benveniste,E.N.Cytokines in inflammatorybrain lesions:Helpfulandharmful.TrendsNeurosci. 1996,19, 331–338. [CrossRef] 8. Maimone,D.;Guazzi,G.C.;Annunziata,P. IL-6detection inmultiplesclerosisbrain. J.Neurol. Sci. 1997,146, 59–65. [CrossRef] 9. Eugster,H.-P.;Frei,K.;Kopf,M.;Lassmann,H.;Fontana,A. IL-6deficientmiceresistmyelinoligodendrocyte glycoprotein-inducedautoimmuneencephalomyelitis.Eur. J. Immunol. 1998,28, 2178–2187. [CrossRef] 10. Mendel, I.; Katz, A.; Kozak, N.; Ben-Nun, A.; Revel, M. Interleukin-6 functions in autoimmune encephalomyelitis:Astudyingene-targetedmice.Eur. J. Immunol. 1998,28, 1727–1737. [CrossRef] 11. Okuda,Y.; Sakoda, S.; Bernard,C.C.; Fujimura,H.; Saeki,Y.;Kishimoto,T.;Yanagihara,T. IL-6-deficient miceare resistant to the inductionof experimental autoimmuneencephalomyelitisprovokedbymyelin oligodendrocyteglycoprotein. Int. Immunol. 1998,10, 703–708. [CrossRef] [PubMed] 12. Samoilova,E.B.;Horton, J.L.;Hilliard,B.;Liu,T.S.;Chen,Y. IL-6-deficientmiceareresistant toexperimental autoimmuneencephalomyelitis: Rolesof IL-6 in theactivationanddifferentiationofautoreactiveTcells. J. Immunol.1998,161, 6480–6486. [PubMed] 13. Giralt,M.;Ramos,R.;Quintana,A.;Ferrer,B.;Erta,M.;Castro-Freire,M.;Comes,G.;Sanz,E.;Unzeta,M.; Pifarré,P.; et al. InductionofatypicalEAEmediatedbytransgenicproductionof IL-6 inastrocytes in the absenceofsystemic IL-6.Glia2013,61, 587–600. [CrossRef] [PubMed] 14. Serada,S.;Fujimoto,M.;Mihara,M.;Koike,N.;Ohsugi,Y.;Nomura,S.;Yoshida,H.;Nishikawa,T.;Terabe,F.; Ohkawara,T.; et al. IL-6blockade inhibits the inductionofmyelinantigen-specificTh17cellsandTh1cells in experimentalautoimmuneencephalomyelitis.Proc.Natl.Acad. Sci.USA2008,105, 9041–9046. [CrossRef] [PubMed] 15. Spooren,A.;Kolmus,K.;Laureys,G.;Clinckers,R.;DeKeyser, J.;Haegeman,G.;Gerlo,S. Interleukin-6,amental cytokine.BrainRes. Rev. 2011,67, 157–183. [CrossRef] [PubMed] 16. Erta,M.;Quintana,A.;Hidalgo, J. Interleukin-6,amajorcytokine inthecentralnervoussystem. Int. J.Biol. Sci. 2012,8, 1254–1266. [CrossRef] [PubMed] 17. Quintana,A.;Erta,M.;Ferrer,B.;Comes,G.;Giralt,M.;Hidalgo, J.Astrocyte-specificdeficiencyofinterleukin-6 and its receptor reveal specific roles in survival, bodyweight andbehavior.BrainBehav. Immun.2013, 27, 162–173. [CrossRef] [PubMed] 18. Erta,M.;Giralt,M.; Esposito, F.L.; Fernandez-Gayol,O.;Hidalgo, J.Astrocytic IL-6mediates locomotor activity,exploration,anxiety, learningandsocialbehavior.Horm.Behav.2015,73,64–74. [CrossRef][PubMed] 19. Su,M.;Hu,H.; Lee,Y.; d’Azzo,A.;Messing,A.; Brenner,M.Expression specificityofGFAP transgenes. Neurochem.Res. 2004,29, 2075–2093. [CrossRef] [PubMed] 20. Mycko,M.P.; Papoian, R.; Boschert,U.; Raine,C.S.; Selmaj, K.W.Cdnamicroarray analysis inmultiple sclerosis lesions:Detectionofgenesassociatedwithdiseaseactivity.Brain2003,126, 1048–1057. [CrossRef] [PubMed] 21. Lock,C.; Hermans,G.; Pedotti, R.; Brendolan,A.; Schadt, E.; Garren,H.; Langer-Gould,A.; Strober, S.; Cannella, B.; Allard, J.; et al. Gene-microarray analysis ofmultiple sclerosis lesions yields new targets validated inautoimmuneencephalomyelitis.Nat.Med. 2002,8, 500–508. [CrossRef] [PubMed] 22. Gijbels,K.;Brocke,S.;Abrams, J.S.; Steinman,L.Administrationofneutralizingantibodies to interleukin-6 (IL-6) reducesexperimentalautoimmuneencephalomyelitisandisassociatedwithelevated levelsof IL-6 bioactivity incentralnervoussystemandcirculation.Mol.Med. 1995,1, 795–805. [PubMed] 23. Willenborg, D.O.; Fordham, S.A.; Cowden, W.B.; Ramshaw, I.A. Cytokines and murine autoimmune encephalomyelitis: Inhibitionorenhancementofdiseasewithantibodies toselect cytokines,orbydelivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 1995, 41, 31–41. [CrossRef] [PubMed] 24. Rodriguez, M.; Pavelko, K.D.; McKinne, C.W.; Leibowitz, J.L. Recombinant human IL-6 suppresses demyelination inaviralmodelofmultiplesclerosis. J. Immunol. 1994,153, 3811–3821. [PubMed] 27